Do analysts rate PAVM or AEMD?

PAVmed presently has a consensus price target of $56.00, suggesting a potential upside of 1,011.11%. Given PAVmed's stronger consensus rating and higher probable upside, equities research analysts plainly believe PAVmed is more favorable than Aethlon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PAVmed 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is PAVM or AEMD more profitable?

Aethlon Medical has a net margin of 0.00% compared to PAVmed's net margin of -21,914.12%. Aethlon Medical's return on equity of -137.73% beat PAVmed's return on equity. Company Net Margins Return on Equity Return on Assets PAVmed -21,914.12% -146.19% -18.39% Aethlon Medical N/A -137.73% -105.87%

Does the media prefer PAVM or AEMD?

In the previous week, PAVmed had 1 more articles in the media than Aethlon Medical. MarketBeat recorded 4 mentions for PAVmed and 3 mentions for Aethlon Medical. PAVmed's average media sentiment score of 0.00 beat Aethlon Medical's score of -0.67 indicating that PAVmed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PAVmed 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Do analysts prefer AEMD or LUCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media favor AEMD or LUCY?

In the previous week, Aethlon Medical had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 3 mentions for Aethlon Medical and 1 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.00 beat Aethlon Medical's score of -0.67 indicating that Innovative Eyewear is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AEMD or SONX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is AEMD or SONX more profitable?

Aethlon Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Aethlon Medical's return on equity of -137.73% beat Sonendo's return on equity. Company Net Margins Return on Equity Return on Assets Aethlon Medical N/A -137.73% -105.87% Sonendo -92.74% -184.01% -68.60%

Do analysts recommend AEMD or ITOC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aethlon Medical 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Itonic 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, AEMD or ITOC?

Itonic has higher revenue and earnings than Aethlon Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aethlon Medical N/A N/A -$7.15M -$14.69 N/A Itonic $520K 9.51 -$5.10M N/A N/A

Is AEMD or ITOC more profitable?

Itonic's return on equity of 0.00% beat Aethlon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Aethlon Medical N/A -137.73% -105.87% Itonic N/A N/A N/A

Does the media favor AEMD or ITOC?

In the previous week, Itonic had 2 more articles in the media than Aethlon Medical. MarketBeat recorded 5 mentions for Itonic and 3 mentions for Aethlon Medical. Itonic's average media sentiment score of 0.22 beat Aethlon Medical's score of -0.67 indicating that Itonic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Itonic 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Aethlon Medical (AEMD) Competitors

$3.25 -0.27 (-7.67%)

Closing price 08/5/2026 04:00 PM Eastern

Extended Trading

$3.16 -0.09 (-2.77%)

As of 04:44 AM Eastern

Compare

AEMD vs. PAVM, LUCY, SONX, CLGN, and ITOC

Should you buy Aethlon Medical stock or one of its competitors? MarketBeat compares Aethlon Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aethlon Medical include PAVmed (PAVM), Innovative Eyewear (LUCY), Sonendo (SONX), CollPlant Biotechnologies (CLGN), and Itonic (ITOC).

How does Aethlon Medical compare to PAVmed?

PAVmed (NASDAQ:PAVM) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

In the previous week, PAVmed had 1 more articles in the media than Aethlon Medical. MarketBeat recorded 4 mentions for PAVmed and 3 mentions for Aethlon Medical. PAVmed's average media sentiment score of 0.00 beat Aethlon Medical's score of -0.67 indicating that PAVmed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PAVmed	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

PAVmed has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market.

19.9% of PAVmed shares are owned by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are owned by institutional investors. 13.4% of PAVmed shares are owned by insiders. Comparatively, 0.7% of Aethlon Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

PAVmed has higher revenue and earnings than Aethlon Medical. Aethlon Medical is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PAVmed	$70K	72.00	$400K	-$37.40	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A

Aethlon Medical has a net margin of 0.00% compared to PAVmed's net margin of -21,914.12%. Aethlon Medical's return on equity of -137.73% beat PAVmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PAVmed	-21,914.12%	-146.19%	-18.39%
Aethlon Medical	N/A	-137.73%	-105.87%

PAVmed presently has a consensus price target of $56.00, suggesting a potential upside of 1,011.11%. Given PAVmed's stronger consensus rating and higher probable upside, equities research analysts plainly believe PAVmed is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

PAVmed beats Aethlon Medical on 11 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Innovative Eyewear?

Aethlon Medical (NASDAQ:AEMD) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

Aethlon Medical has higher earnings, but lower revenue than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A
Innovative Eyewear	$2.66M	1.72	-$7.59M	-$1.69	N/A

2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 0.7% of Aethlon Medical shares are owned by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Aethlon Medical has a net margin of 0.00% compared to Innovative Eyewear's net margin of -272.42%. Innovative Eyewear's return on equity of -83.37% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-137.73%	-105.87%
Innovative Eyewear	-272.42%	-83.37%	-76.02%

In the previous week, Aethlon Medical had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 3 mentions for Aethlon Medical and 1 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.00 beat Aethlon Medical's score of -0.67 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Aethlon Medical has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.72, meaning that its stock price is 172% more volatile than the broader market.

Summary

Innovative Eyewear beats Aethlon Medical on 7 of the 12 factors compared between the two stocks.

How does Aethlon Medical compare to Sonendo?

Aethlon Medical (NASDAQ:AEMD) and Sonendo (NYSE:SONX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Aethlon Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Aethlon Medical's return on equity of -137.73% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-137.73%	-105.87%
Sonendo	-92.74%	-184.01%	-68.60%

Aethlon Medical has higher earnings, but lower revenue than Sonendo. Aethlon Medical is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A
Sonendo	$44.40M	0.11	-$60.92M	-$71.12	N/A

Aethlon Medical has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Sonendo has a beta of 1.86, indicating that its stock price is 86% more volatile than the broader market.

In the previous week, Aethlon Medical had 3 more articles in the media than Sonendo. MarketBeat recorded 3 mentions for Aethlon Medical and 0 mentions for Sonendo. Sonendo's average media sentiment score of 0.00 beat Aethlon Medical's score of -0.67 indicating that Sonendo is being referred to more favorably in the news media.

Company	Overall Sentiment
Aethlon Medical	Negative
Sonendo	Neutral

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 0.7% of Aethlon Medical shares are held by insiders. Comparatively, 7.9% of Sonendo shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Sonendo beats Aethlon Medical on 7 of the 13 factors compared between the two stocks.

How does Aethlon Medical compare to CollPlant Biotechnologies?

CollPlant Biotechnologies (NASDAQ:CLGN) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership.

Aethlon Medical has a net margin of 0.00% compared to CollPlant Biotechnologies' net margin of -683.68%. Aethlon Medical's return on equity of -137.73% beat CollPlant Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CollPlant Biotechnologies	-683.68%	-218.81%	-139.28%
Aethlon Medical	N/A	-137.73%	-105.87%

21.7% of CollPlant Biotechnologies shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 9.6% of CollPlant Biotechnologies shares are held by insiders. Comparatively, 0.7% of Aethlon Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Aethlon Medical had 3 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 3 mentions for Aethlon Medical and 0 mentions for CollPlant Biotechnologies. CollPlant Biotechnologies' average media sentiment score of 0.00 beat Aethlon Medical's score of -0.67 indicating that CollPlant Biotechnologies is being referred to more favorably in the media.

Company	Overall Sentiment
CollPlant Biotechnologies	Neutral
Aethlon Medical	Negative

CollPlant Biotechnologies presently has a consensus target price of $11.50, suggesting a potential upside of 3,608.48%. Given CollPlant Biotechnologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe CollPlant Biotechnologies is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CollPlant Biotechnologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Aethlon Medical has lower revenue, but higher earnings than CollPlant Biotechnologies. Aethlon Medical is trading at a lower price-to-earnings ratio than CollPlant Biotechnologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CollPlant Biotechnologies	$389K	11.51	-$11.49M	-$1.45	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A

CollPlant Biotechnologies has a beta of 1.67, meaning that its stock price is 67% more volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

Summary

CollPlant Biotechnologies beats Aethlon Medical on 10 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Itonic?

Aethlon Medical (NASDAQ:AEMD) and Itonic (NASDAQ:ITOC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

Aethlon Medical has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market. Comparatively, Itonic has a beta of 2.81, indicating that its share price is 181% more volatile than the broader market.

Itonic's return on equity of 0.00% beat Aethlon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-137.73%	-105.87%
Itonic	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Itonic had 2 more articles in the media than Aethlon Medical. MarketBeat recorded 5 mentions for Itonic and 3 mentions for Aethlon Medical. Itonic's average media sentiment score of 0.22 beat Aethlon Medical's score of -0.67 indicating that Itonic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Itonic	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Itonic has higher revenue and earnings than Aethlon Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$14.69	N/A
Itonic	$520K	9.51	-$5.10M	N/A	N/A

2.0% of Aethlon Medical shares are owned by institutional investors. 0.7% of Aethlon Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Itonic beats Aethlon Medical on 7 of the 10 factors compared between the two stocks.

Get Aethlon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AEMD vs. The Competition

Export

Metric	Aethlon Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.29M	$5.80B	$6.86B	$12.98B
Dividend Yield	N/A	1.78%	2.60%	9.79%
P/E Ratio	-0.22	23.50	280.40	25.25
Price / Sales	N/A	58.74	560.36	77.68
Price / Cash	N/A	32.67	71.79	50.79
Price / Book	0.21	6.12	12.94	6.09
Net Income	-$7.15M	$151.74M	$3.49B	$347.95M
7 Day Performance	14.84%	3.52%	2.43%	3.08%
1 Month Performance	-17.72%	-1.61%	-2.86%	-3.01%
1 Year Performance	-94.49%	8.96%	75.40%	20.49%

Aethlon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AEMD Aethlon Medical	0.6109 of 5 stars	$3.25 -7.7%	N/A	-94.6%	$2.29M	N/A	N/A	10	News Coverage Upcoming Earnings Gap Down High Trading Volume
PAVM PAVmed	2.7179 of 5 stars	$5.38 +3.5%	$56.00 +940.9%	-65.7%	$5.18M	$70K	N/A	90	News Coverage Upcoming Earnings Gap Up
LUCY Innovative Eyewear	0.4591 of 5 stars	$0.74 -4.3%	N/A	-63.8%	$4.96M	$2.66M	N/A	9	News Coverage Upcoming Earnings Gap Down
SONX Sonendo	N/A	$1.01 flat	N/A	+4,490.9%	$4.82M	$44.40M	N/A	250	Upcoming Earnings
CLGN CollPlant Biotechnologies	2.671 of 5 stars	$0.32 -0.9%	$11.50 +3,539.2%	-86.2%	$4.60M	$2.37M	N/A	70	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AEMD) was last updated on 8/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aethlon Medical (AEMD) Competitors

AEMD vs. PAVM, LUCY, SONX, CLGN, and ITOC

How does Aethlon Medical compare to PAVmed?

Summary

How does Aethlon Medical compare to Innovative Eyewear?

Summary

How does Aethlon Medical compare to Sonendo?

Summary

How does Aethlon Medical compare to CollPlant Biotechnologies?

Summary

How does Aethlon Medical compare to Itonic?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aethlon Medical (AEMD) Competitors

AEMD vs. PAVM, LUCY, SONX, CLGN, and ITOC

How does Aethlon Medical compare to PAVmed?

Does the media prefer PAVM or AEMD?

Which has more risk and volatility, PAVM or AEMD?

Do insiders and institutionals hold more shares of PAVM or AEMD?

Which has preferable valuation & earnings, PAVM or AEMD?

Is PAVM or AEMD more profitable?

Do analysts rate PAVM or AEMD?

Summary

How does Aethlon Medical compare to Innovative Eyewear?

Which has better valuation and earnings, AEMD or LUCY?

Do insiders & institutionals have more ownership in AEMD or LUCY?

Do analysts prefer AEMD or LUCY?

Is AEMD or LUCY more profitable?

Does the media favor AEMD or LUCY?

Which has more risk and volatility, AEMD or LUCY?

Summary

How does Aethlon Medical compare to Sonendo?

Do analysts recommend AEMD or SONX?

Is AEMD or SONX more profitable?

Which has higher earnings & valuation, AEMD or SONX?

Which has more risk and volatility, AEMD or SONX?

Does the media favor AEMD or SONX?

Do institutionals & insiders hold more shares of AEMD or SONX?

Summary

How does Aethlon Medical compare to CollPlant Biotechnologies?

Is CLGN or AEMD more profitable?

Do institutionals and insiders have more ownership in CLGN or AEMD?

Does the media refer more to CLGN or AEMD?

Do analysts prefer CLGN or AEMD?

Which has stronger earnings and valuation, CLGN or AEMD?

Which has more risk and volatility, CLGN or AEMD?

Summary

How does Aethlon Medical compare to Itonic?

Which has more volatility & risk, AEMD or ITOC?

Is AEMD or ITOC more profitable?

Do analysts recommend AEMD or ITOC?

Does the media favor AEMD or ITOC?

Which has better valuation & earnings, AEMD or ITOC?

Do institutionals & insiders have more ownership in AEMD or ITOC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools